VIDEO
HIGHLIGHT
Log InSign up
11ª Aula: Ansiedade, Saúde Mental e a Cannabis sativa L. - Professor Wilson Lessa
SummaryTranscriptChat

11ª Aula: Ansiedade, Saúde Mental e a Cannabis sativa L. - Professor Wilson Lessa

The Role of Cannabinoids in Relaxation and Sleep

This section discusses the role of cannabinoids in relaxation and sleep, based on research conducted by Marzo Viscenzo in 1998.

Cannabinoid System and Anti-Analytic Effect

  • Italian research by Marzo Viscenzo hypothesized the role of cannabinoids in relaxation and sleep.
  • Relaxation and sleep are associated with an anti-analytic effect, which involves a decrease in the naturalness of the cannabinoid system.
  • Antagonizing the CP1 cannabinoid receptor can lead to a decrease in relaxation and sleep.

Deficiency in Enzyme Production

  • Sympathica Joel Kämer discovered a deficiency in the enzyme that degrades our main cannabinoids.
  • This deficiency was identified through surgery when she did not feel pain and did not require analgesic medications.
  • The deficiency results from a microdeletion in the gene that produces the FAAH enzyme responsible for degrading cannabinoids.

Lack of Pain Sensation and Anxiety Reactions

  • Individuals with this deficiency do not feel pain or experience physiological reactions to anxiety.
  • Higher levels of cannabinoids in their blood may contribute to these effects.
  • This deficiency highlights the importance of the cannabinoid system in modulating pain sensation and anxiety reactions.

Efficacy of Cannabinoids for Anxiety Symptoms during COVID-19

This section discusses a study conducted at Uspi University on the efficacy of cannabinoids for reducing anxiety symptoms among health professionals during the COVID-19 pandemic.

Study Design and Results

  • The study evaluated the efficacy and safety of cannabinoids compared to placebo among health professionals during COVID-19.
  • Results showed a significant reduction (60%) in anxiety symptoms, as well as reductions (50%) in depression symptoms and burnout (25%).
  • The study analyzed data after 14 and 28 days of cannabinoid use.

Chronic Anxiety and Immune Response

This section explores the impact of chronic anxiety on mental health and immune response.

Effects of Chronic Anxiety

  • Chronic anxiety can lead to up to 10,000 mental trans-sounds.
  • Excessive or chronic anxiety can have detrimental effects on mental well-being.
  • Immune protection may be compromised in individuals with exaggerated anxiety responses.

The transcript provided does not contain enough information for further sections.

New Section

This section discusses the similarities and treatment options for stress-related disorders and mental health issues.

Similarities between Stress-Related Disorders and Mental Health

  • Both stress-related disorders and mental health issues have similarities in their treatment approaches.
  • The therapy for both conditions involves behavioral interventions and the use of certain medications.
  • Serotonin inhibitors, such as citalopram, fluoxetine, sertraline, and noradrenaline inhibitors are commonly used in therapy.

Undesired Effects of Treatment

  • The use of benzodiazepines in treatment can lead to a risk of dependency, especially when not adhering to the prescribed dosage.
  • Cognitive and psychomotor impairments are common side effects of benzodiazepines.
  • Antidepressants may cause sexual dysfunction, difficulty organizing, weight gain, insomnia, among other effects.

Role of Cannabinoids in Emotional Regulation

  • Cannabinoids have been studied for their potential role in emotional regulation.
  • THC, an agonist of the C1 receptor, has been found to reduce anxiety and induce relaxation.
  • Endocannabinoid signaling plays a critical role in regulating body systems' response to stress.

Cannabis Use for Anxiety

  • Initial cannabis use is associated with a reduction in anxiety symptoms.
  • Chronic cannabis use can worsen anxiety symptoms and even contribute to panic attacks.
  • Medical cannabis with high THC content may increase anxiety levels.

Personal Experience with Cannabis Use

  • The speaker shares a personal experience related to cannabis use from 18 years ago until recently.
  • Low THC content cannabis from Guyana had medical and ritualistic use.
  • Over time, high THC content cannabis became more prevalent, leading to increased anxiety in some patients.

New Section

This section introduces the therapeutic course on the sativa channel and addresses anxiety-related topics.

Introduction to the Therapeutic Course

  • The speaker welcomes viewers to another lesson of the non-edition course on therapeutic therapy.
  • The course is presented by the Sativa Channel.

Cannabis Use and Anxiety

  • Cannabis has been studied for its effects on anxiety reduction and relaxation.
  • Activation of the C1 receptor through THC agonism plays a role in reducing anxiety.
  • Recent evidence suggests that enhancing endocannabinoid signaling may be promising for stress and anxiety treatment.

Personal Experience with Cannabis Use

  • The speaker shares a personal experience related to cannabis use from 18 years ago until recently.
  • Low THC content cannabis from Guyana had medical and ritualistic use.
  • Over time, high THC content cannabis became more prevalent, leading to increased anxiety in some patients.

Answering Questions via Chat or Email

In this section, the speaker emphasizes that questions asked through chat or email will be answered promptly.

Prompt Response to Queries

  • Questions sent via chat or email are answered promptly.

Difference in THC Content and Video Orientation

The speaker discusses the difference in THC content and highlights the importance of watching the video orientation.

Understanding THC Content

  • There are different orientations regarding THC content.
  • It is recommended to watch the video orientation to gain a better understanding.

Anxiety Symptoms and Video Availability

The speaker explains how anxiety symptoms can be caused by cannabis and mentions the availability of all videos on YouTube.

Anxiety Symptoms and Cannabis Use

  • Cannabis use can cause symptoms of anxiety in some individuals.

Video Availability

  • All videos from this edition are available on a playlist on YouTube.

Cannabis Not Necessarily Causing Anxiety

The speaker clarifies that cannabis does not necessarily cause anxiety.

No Direct Link Between Cannabis and Anxiety

  • It is not necessary to assume that cannabis directly causes anxiety.

Topics Covered in Previous Editions

The speaker mentions that previous editions covered various topics of interest.

Topics Covered in Previous Editions

  • Previous editions covered a range of topics that may be of interest to viewers.

Importance of Orientation for Patients

The speaker highlights the importance of orientation for patients.

Benefits of Orientation

  • Orientation can be beneficial for many patients.

Course Presentation and Pandemic Impact

The speaker discusses the course presentation and its impact during the pandemic.

Course Presentation During Pandemic

  • The course was presented during the pandemic, which initially affected its format.

Frequently Asked Questions about Formulas

The speaker addresses common doubts regarding formulas.

Clarifying Formula Doubts

  • Common doubts regarding formulas are addressed in this section.

THC Content Variation in Formulas

The speaker explains the variation in THC content among different formulas.

Variation in THC Content

  • Different formulas may have varying levels of THC content.

Importance of Cannabis Pattern Change

The speaker emphasizes the significance of changing cannabis patterns.

Significance of Changing Cannabis Patterns

  • Changing cannabis patterns can have a significant impact on individuals.

Sending Presence Confirmation via Link

The speaker explains how to send presence confirmation through a provided link.

Sending Presence Confirmation

  • Viewers can send their presence confirmation by clicking on the link provided in the video description.

Retention and Correction of Confirmation Error

The speaker discusses retention and correction related to presence confirmation.

Retention and Correction Process

  • There was an error with confirmation configuration in some classes, but it has been corrected.

No Prejudice in Sending Confirmation Multiple Times

The speaker assures viewers that there is no prejudice in sending confirmation multiple times.

Sending Confirmation Multiple Times

  • Viewers can send their confirmation as many times as necessary without any negative consequences.

Effects of Low THC Doses

The speaker discusses the effects of low THC doses.

Anti-Anxiety Effects of Low THC Doses

  • Low THC doses have anti-anxiety effects and do not cause significant alterations.

Introduction to Dr. Wilson Lesson

The speaker introduces Dr. Wilson Lesson, a psychiatrist who will discuss cannabis use for anxiety.

Introduction to Dr. Wilson Lesson

  • Dr. Wilson Lesson, a psychiatrist, will talk about the use of cannabis for anxiety and psychiatric cases.

Stress and Anxiety Induced by High THC Doses

The speaker explains how high THC doses can induce stress and anxiety.

Stress and Anxiety from High THC Doses

  • Chronic administration of high THC doses increases stress and anxiety in animals.

Mental Health and Cannabis System

The speaker discusses mental health and the role of cannabis in the body's system.

Mental Health and Cannabis System

  • Cannabis plays a role in mental health within the body's system.

Role of Cannabis in Disease Treatment

The speaker highlights the potential role of cannabis in disease treatment.

Potential Role of Cannabis in Disease Treatment

  • Cannabis may have therapeutic potential for various diseases.

THC Dose Classification

The speaker explains the classification of THC doses.

THC Dose Classification

  • THC doses are classified as low, medium, and high based on milligram ranges.

Medication Reminder

The speaker provides a reminder regarding medication.

Medication Reminder

  • The speaker reminds viewers about the importance of medication.

The Role of Rimonabant in Cannabis and Health

This section discusses the role of Rimonabant, a medication used to reduce appetite, in relation to cannabis and health.

Rimonabant and THC Content

  • A 1-gb cigarette contains approximately 200 milligrams of THC.
  • Rimonabant is different from a typical 5 milligram dose of THC used for anxiety or pain relief.
  • Rimonabant acts as an antagonist on the CB1 receptor, which is involved in the effects of cannabis.

Effects and Side Effects

  • Rimonabant was initially thought to reduce appetite and body fat but had unexpected side effects.
  • Activation of the CB1 receptor can lead to serious collateral effects such as anxiety, panic, depression, and even suicide.
  • Inhibitory neurons related to the central nervous system are affected by Rimonabant.

Modulation of the Cannabinoid System

  • Rimonabant affects specific circuits related to stress response.
  • Modulating the cannabinoid system can have positive effects on anxiety control.
  • Cannabinoids play a role in fetal development and controlling anxiety levels.

Functions of the CB1 Receptor

  • The CB1 receptor is involved in relaxation, protection, eating, sleeping, and forgetting.
  • Activation of the CB1 receptor decreases neurotransmitter elimination, leading to anti-anxiety effects.

Case Study: Deficiency in Enzyme Production

  • A case study involving a deficiency in the enzyme that degrades cannabinoids.
  • Deficiency in this enzyme can lead to an anesthetic effect and reduced physiological reactions to anxiety.

Activation of CB1 Receptor

  • Activation of the CB1 receptor leads to relaxation and anti-anxiety effects.

The transcript is not in English, but the summary has been provided in English as requested.

New Section

This section discusses the effects of inhibiting neurons and the activation of cannabinoid receptors in relation to pain, anxiety, and physiological reactions.

Inhibitor Neurons and Lack of Pain/Anxiety

  • Inhibitor neurons prevent feeling pain and having physiological reactions to anxiety.
  • When inhibiting these neurons is inhibited, it can lead to activation and inconvenience.
  • High doses of THC can activate cannabinoid receptors in inhibitory neurons, causing anxiety and pain.

Efficacy and Safety of Cannabinoids

  • A study conducted on health professionals during the COVID-19 period showed a reduction in anxiety symptoms by 60%, depression symptoms by 50%, and burnout by 25% with the use of cannabinoids compared to a placebo.
  • Higher dosages were used in this study, but it demonstrated the potential benefits of cannabinoids in reducing anxiety.

Pharmacological Interaction and Anxiety Disorders

  • Excessive or chronic activation of cannabinoid receptors can lead to increased anxiety.
  • The interaction between cannabinoid receptor CB2 and autonin receptor A can have an anxiogenic effect.
  • Certain medications, like spironolactone, can exacerbate anxiety symptoms.

Treatment Approaches for Anxiety Disorders

  • Therapy is commonly used for treating anxiety disorders.
  • The combination of cognitive-behavioral therapy with anxiolytic effects of cannabinoids may be beneficial.
  • Serotonin plays a role in moderate doses of cannabinoids for anxiety treatment.

New Section

This section focuses on a study conducted on health professionals during the COVID-19 period to evaluate the efficacy of cannabinoids in reducing anxiety, depression, and burnout symptoms.

Study on Health Professionals and Cannabinoids

  • The study showed a significant reduction in anxiety symptoms by 60%, depression symptoms by 50%, and burnout by 25% with the use of cannabinoids compared to a placebo.
  • The reduction in symptoms was observed after 14 and 28 days of cannabinoid treatment.

New Section

This section discusses the relationship between cannabinoid receptors and different types of anxiety disorders, such as social anxiety and post-traumatic stress disorder (PTSD).

Cannabinoid Receptors and Anxiety Disorders

  • Cannabinoid receptor CB1 has an agonizing action on the receptor 5HT1A, which is involved in anxiety regulation.
  • Social anxiety and PTSD are classified under different groups but share similarities in terms of cannabinoid receptor activation.

Treatment Approaches for Anxiety Disorders

  • Therapy, particularly cognitive-behavioral therapy, is commonly used for treating anxiety disorders.
  • Anxiolytic effects of cannabinoids can complement therapy approaches.
  • Moderate doses of purified cannabinoids can have anxiolytic effects without causing sedation.

These summaries provide an overview of the main points discussed in each section. They are concise and organized to facilitate studying the transcript.

Psychological Options for Increasing Positive Effects

In this section, the speaker discusses various psychological options to increase positive effects.

Psychological Options for Increasing Positive Effects

  • The speaker mentions increasing the dose of certain medications such as pre-gabapentin, psychedelics, and buspirone. However, they caution against using moclobemide and benzodiazepines.
  • It is noted that even with a certain dose, 40% of patients may still experience residual symptoms if they do not adhere to the treatment or face difficulties.
  • The speaker highlights the importance of accessing treatment and cautions against relying solely on purified cannabidiol (CBD).

Undesired Effects of Pharmacological Treatments

This section focuses on the undesired effects of pharmacological treatments.

Undesired Effects of Pharmacological Treatments

  • The speaker explains that some medications, like benzodiazepines, carry a risk of dependency. Additionally, CBD can have an anxiogenic effect and an incidence of abstinence similar to benzodiazepines.
  • It is mentioned that CBD does not create tolerance like benzodiazepines do and has fewer cognitive and psychomotor side effects. However, there may be instances where CBD loses its anxiolytic effect or causes insomnia.
  • Preclinical evidence suggests that CBD may cause sexual dysfunction and difficulty in organizing tasks similar to other antidepressants. Weight gain can also be a collateral effect of antidepressant medications.

Potential Use of CBD as an Effective Treatment

This section discusses the potential use of CBD as an effective treatment.

Potential Use of CBD as an Effective Treatment

  • The speaker mentions that preclinical evidence supports the potential of CBD to serve as an effective treatment for anxiety disorders, trauma-related stress, and other conditions.
  • It is noted that further research is needed to explore the effectiveness of CBD in treating anxiety disorders and related conditions.

Preclinical Evidence and Safety Profile

This section focuses on preclinical evidence and the safety profile of CBD.

Preclinical Evidence and Safety Profile

  • The speaker explains that preclinical studies conducted on animal models have shown positive effects of CBD in emotional behavior. Human studies have also indicated that CBD is safe and well-tolerated.
  • A doctor from California, Dr. Bonnie Goldstein, has observed positive outcomes in patients using moderate THC alongside CBD. However, more research is needed to fully understand the benefits and risks associated with THC use.

THC's Impact on Mood and Anxiety

This section explores the impact of THC on mood and anxiety.

THC's Impact on Mood and Anxiety

  • The speaker discusses how continuous use of moderate THC doses can activate C-1 receptors, leading to a decrease in receptor expression over time. This may result in tolerance development, requiring higher doses for desired effects.
  • It is mentioned that some patients experience pain relief through endocannabinoid modulation but may develop tolerance over time. Strategies such as intermittent dosing or using products with lower THC content can help mitigate tolerance issues.

Conclusion

The conclusion of the transcript is not available.

The transcript provided does not include a clear conclusion.

The Use of Cannabis for Anxiety Reduction

This section discusses the use of cannabis as a therapy for reducing anxiety symptoms. It explores the relationship between THC and CBD concentrations, the impact of chronic cannabis use on anxiety, and the potential therapeutic effects of THC.

The Role of THC and CBD in Anxiety Reduction

  • Initial use of cannabis is associated with a reduction in symptom intensity.
  • Chronic use of cannabis can lead to tolerance for THC and worsen anxiety symptoms.
  • High-medical anxiety can be treated using cannabis with a high concentration of CBD compared to THC (18:1.25:1.2 ratio).

Personal Experience with Cannabis Therapy

  • Patients with 3-symptomatic stress transfer may find it challenging to settle on an effective treatment.
  • Personal experience working with patients who used high-THC Chimewariant cannabis from Vorai.
  • A shift occurred approximately 9 years ago towards low-medical anxiety cannabis.

Historical Context and Therapeutic Potential

  • Cannabis introduced in the 17th century by Africans and Indians had lower THC content but effectively reduced anxiety without sedation.
  • Cannabis brought from Giana around the 18th century had higher THC content, which led to concerns about its impact on anxiety.
  • THC has sedative effects that can be useful for managing anxiety, but it also has calming effects.

Therapeutic Effects and Different Cannabis Strains

  • Many patients reported positive experiences using high-THC strains for anxiety relief.
  • Cannabis strains with high terpene content, such as limonene and lavender, may alleviate anxiety symptoms.
  • High-temperature plants with higher THC content can exacerbate anxiety symptoms.

THC Dosage and Memory Effects

  • Controlling THC dosage is crucial for managing anxiety effectively.
  • THC can help improve memory fixation but may also cause memory-related trauma.
  • Changes in cannabis patterns, with higher THC content, have raised concerns about their impact on anxiety.

Research and Conclusion

  • A systematic review conducted by Marcia Albomila in 2017 explored the use of cannabis for mental health.
  • Studies have shown that THC affects nervous tension and retention of tension.

New Section

This section discusses the effects of low THC doses and the administration of high THC doses on mental health.

Effects of Low THC Doses

  • Low THC doses in the past have shown anti-analytical effects.
  • A study from 2017 suggests that low THC doses have positive effects on the majority of people.
  • Chronic administration of high THC doses produces anti-aging effects but can also lead to anxiety and stress.

Administration of High THC Doses

  • High THC doses have been found to increase anxiety in animals.
  • Cannabis has potential for treating certain conditions, such as increasing neuronal activity in specific brain circuits.
  • The use of cannabis for substance use disorders should be carefully monitored, with lower doses being preferred.

Dosage Considerations

  • Low THC doses range from 7 to 18 milligrams and are considered safe.
  • Higher doses above 18 milligrams are classified as high dose and may have different effects.
  • More research is needed to understand the impacts of medicinal cannabis on health at different dosage levels.

New Section

This section explores the relationship between THC dosage and its impact on individuals, including considerations for patients with anxiety or behavioral disorders.

Impact of Different Dosages

  • Studies suggest that a cigarette containing 1 gram with 20% THC would provide approximately 200 milligrams of THC.
  • Different dosages can have varying effects on individuals, such as those with autism spectrum disorder or anxiety.
  • Patients using medicinal cannabis should consult with healthcare professionals to determine appropriate dosage based on their specific condition.

Genetic Factors

  • Research indicates that genetic factors play a role in how individuals respond to THC.
  • The activation of the C-B1 receptor gene influences the effects of THC on neuronal activity.
  • Different genetic variations may require different dosage strategies for optimal results.

Neuronal Activity and Dosage

  • THC preparations can affect neuronal activity, particularly in excitatory and inhibitory neurons.
  • The activation of the C-B1 receptor plays a role in regulating neurotransmitters like glutamate.
  • Optimal dosages aim to prevent anxiety symptoms by modulating glutamate neurons.

New Section

This section discusses the recommended dosage for THC intake, especially before sleep, and its impact on neurotransmitters.

Recommended Dosage

  • For individuals using THC before sleep, a dosage range of 5 to 20 milligrams per day is often recommended.
  • Higher doses may have an excitogenic effect and should be used with caution.
  • The decrease in elimination of neurotransmitters is associated with activating the C-B1 receptor.

Neurotransmitter Regulation

  • THC preparations can regulate neurotransmitters like glutamate and corticases.
  • Excitatory neurons are dominant during wakefulness, while inhibitory neurons play a role in relaxation and sleep.
  • Proper dosage aims to balance neurotransmitter activity for optimal mental state.

These notes provide an overview of the transcript's content, highlighting key points related to low and high THC doses, their effects on mental health, considerations for different dosages, genetic factors influencing response to THC, and regulation of neurotransmitters.

New Section

This section discusses the effects of cannabinoids on anxiety and the role of the C-B1 receptor.

Effects of Cannabinoids on Anxiety

  • The decrease in the elimination of neurotransmitters leads to a decrease in anxiety.
  • Low-density of neurotransmitters is associated with increased anxiety.
  • Cannabinoids have an anxiolytic effect but can also cause collateral effects.
  • Cortical activity and ephetanciogenic effects are involved in cannabinoid treatment for anxiety.
  • Higher doses of cannabinoids can lead to increased anxiety due to their impact on VH receptors.
  • Activation of the C-B1 receptor by cannabinoids can be beneficial for anxiety treatment.

Strategies for Treating Anxiety with Cannabinoids

  • Inhibiting neurons that use neurotransmitters like GABA can help reduce anxiety symptoms.
  • THC, even at low doses, can increase anxiety levels in some individuals.
  • Sensitivity to THC varies among patients, and some may experience increased anxiety.
  • The caabaedic neurons and receptors play a crucial role in cannabinoid treatment for anxiety.

Safety and Efficacy of Cannabinoid Treatment

  • Caabaedial has been tested as a safe option for treating anxiety, even at high doses.
  • Caabaedial has a broad therapeutic profile without sedative effects.
  • Caabaedial is considered safe and non-sedative, making it suitable for patients who desire cannabinoids' benefits without sedation.

Pharmacological Profile and Interactions

  • Decreasing the dose of cannabinoids gradually can help manage anxiety symptoms effectively.
  • Cannabinoids interact with various receptors, including c-bomotor and 5-H-T-M-A receptors.
  • Activation of certain receptors by cannabinoids can improve anxiety symptoms over time.

Ephetanciolithic Effects and Treatment Success

  • Higher levels of caabaedial contribute to the ephetanciolithic effect in treating anxiety.
  • Moderate doses of purified caabaedial have a higher chance of treatment success for anxiety.

New Section

This section discusses the ephetanciogenic effect of high doses of THC on anxiety.

Ephetanciogenic Effect of High Doses of THC

  • High doses of THC can lead to an increase in anxiety levels due to its ephetanciogenic effect.

New Section

This section explores strategies for decreasing epinemids and managing anxiety symptoms.

Strategies for Decreasing Epinemids and Managing Anxiety

  • Gradually decreasing epinemids dosage can be an effective strategy for managing anxiety symptoms.
  • The use of cannabinoids may interact with the c-bomotor receptor and have an agonizing action.
  • Activation of certain receptors by cannabinoids can improve anxiety symptoms over time.

New Section

This section discusses the relationship between dosage and treatment success in using caabaedial for anxiety.

Dosage and Treatment Success with Caabaedial

  • Increasing the dosage of caabaedial may lead to a greater chance of treatment success for anxiety patients.

The transcript provided is not in English. However, I have summarized the content based on the given timestamps.

New Section

In this section, the speaker discusses the ephetanciolithic effect of a certain dosage and the potential decrease or loss of this effect.

Ephetanciolithic Effect and CBD

  • The ephetanciolithic effect starts to diminish at a certain dosage.
  • The caabaedial purified may terminate this effect.
  • CBD has crucial ephetanciogenic effects.
  • Studies on CBD reveal its impact on ephetanciolithic effects.
  • Chronic exposure to CBD affects epinemids.

New Section

This section focuses on the potential use of CBD as an effective treatment for anxiety symptoms and traumatic stress.

CBD as Treatment for Anxiety and Traumatic Stress

  • Preclinical evidence supports the use of CBD with antidepressants for anxiety treatment.
  • Clinical practice shows positive results in patients using moderate THC doses intermittently.
  • However, increased THC usage can lead to higher risk and cognitive impairment.

New Section

Here, the speaker discusses strategies to reduce tolerance and decrease cognitive impairment associated with high THC doses.

Reducing Tolerance and Cognitive Impairment

  • Gradually reducing THC dosage can help decrease tolerance levels.
  • Altering cannabinoid receptor expression through therapy can aid in decreasing tolerance.
  • Patients should consider intermittent cannabis usage to avoid developing tolerance.